New this year! Don’t miss more than 30 sessions catering to the interest of genetic counselors working in cardiovascular electrophysiology. Learn more about our educational opportunities and NSGC accreditation.
The National Society of Genetic Counselors (NSGC) has authorized the Heart Rhythm Society to offer up to 2.3 CEUs or 23 Category 1 contact hours for the event Heart Rhythm 2017 Scientific Sessions. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
Claiming Genetic Counselor CEUs
1. Participants seeking National Society of Genetic Counselors (NSGC) credit are required to complete each session evaluation and a meeting evaluation in order to claim CEUs.
2. Once you have added all sessions to your credit cart, on your “My Credit Cart/Certificate of Participation” tab, located to the right is an “Evaluate Session” link.
3. Select the link and complete an evaluation for each session for which you are claiming NSGC credit.
4. Once you have completed all session evaluations, select “Certification of Participation – NSGC” on the right of the screen to generate your certificate. You must complete each session evaluation & select “Certification of Participation – NSGC” in order to receive credit.
HRS will notify the National Society of Genetic Counselors (NSCG) of your participation no later than June 15, 2017. Note: Individuals participating in the NSGC session(s) and wishing to claim credit were required to enter their member ID and pay a processing fee at the time of registration. This fee cannot be paid post conference.
Wednesday, May 10
C-SP04. Inside Pandora's Box: Implications of ACMG Secondary Findings for Cardiology Clinical Practice
Session Description: In 2013 the American College of Medical Genetics (ACMG) released recommendations for the reporting of secondary findings in clinical exome and genome sequencing (WES/WGS), which advised reporting of pathogenic or likely pathogenic variants in 20 genes associated with inherited arrhythmia and cardiomyopathy conditions. This session will review the ACMG recommendations for reporting secondary findings and discuss the impact of these recommendations on cardiology clinical practice. Using case examples, this session will specifically address the broad implications of these findings for the patient, family and health care system as well as the critical role of the multidisciplinary team.
Thursday, May 11
C-SP19. Escaping (or Accepting) Genetic Purgatory
Session Description: As cardiovascular genetic testing panels grow in gene quantity and clinical exome/genome sequencing begins to be offered to patients with inherited heart diseases, providers will receive an increasing number of variants of uncertain significance. This session will discuss the impact of a patient's phenotype and family history on the likelihood of finding and understanding a variant of uncertain significance (VUS), how a clinician may facilitate the reclassification of a VUS to pathogenic or benign, and what to do when genetic test results remain equivocal. The session will conclude with national efforts to help solve the challenge of gene variant interpretation.
Friday, May 12
C-SP25. Cardiac Arrests in Patients with Acute Heart Failure: Is it really Myocarditis?
Session Description: Individuals who present with cardiac arrests and acute heart failure are often assumed to have myocarditis; however, that is not always the case. Correctly identifying the etiology of the cardiac arrests in these cases has important implications for not only the patient, but also for family members. Learn strategies to differentiate between myocarditis and other causes of cardiac arrests in patients with acute heart failure, including genetic cardiomyopathies.